Trial intelligence / Profile preview

Lower- versus standard-loading-dose nifedipine for threatened preterm labor and maternal hypotension

ACTRN12612000517875Phase 3Recruiting

Sponsor
Khon Kaen Hospital
Start
May 2012
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, open-label trial of nifedipine in Preterm labor (PTL) (2 arms), sponsored by Khon Kaen Hospital. Primary endpoint: Incidence of hypotension. Started May 2012; status: recruiting.

02

Drugs

nifedipine
03

Conditions

Preterm labor (PTL)

Beyond the preview

Go deeper on ACTRN12612000517875.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ACTRN12612000517875.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call